Tackling bias in clinical trials

Affiliations

¹ Director of ECFS Clinical Trials Network (ECFS-CTN) CF Centre Cologne, University Children's Hospital, Faculty of Medicine, University of Cologne, Germany. Electronic address: Silke.vanKoningsbruggen@uk-koeln.de.
² Co-Director of ECFS Clinical Trials Network (ECFS-CTN) Centre for Experimental Medicine, Queen's University Belfast, UK. Electronic address: d.downey@qub.ac.uk.

Free article

Editorial

Silke van Koningsbruggen-Rietschel et al. J Cyst Fibros. 2019 Jul.

Free article

. 2019 Jul;18(4):445-446.

doi: 10.1016/j.jcf.2019.06.001.

¹ Director of ECFS Clinical Trials Network (ECFS-CTN) CF Centre Cologne, University Children's Hospital, Faculty of Medicine, University of Cologne, Germany. Electronic address: Silke.vanKoningsbruggen@uk-koeln.de.
² Co-Director of ECFS Clinical Trials Network (ECFS-CTN) Centre for Experimental Medicine, Queen's University Belfast, UK. Electronic address: d.downey@qub.ac.uk.

No abstract available

Comment on

Do patients with cystic fibrosis participating in clinical trials demonstrate placebo response? A meta-analysis.
Coton J, Le HH, Veuillet V, Janiaud P, Cucherat M, Kassai-Koupai B, Gueyffier F, Reix P. Coton J, et al. J Cyst Fibros. 2019 Jul;18(4):461-467. doi: 10.1016/j.jcf.2019.02.003. Epub 2019 Feb 13. J Cyst Fibros. 2019. PMID: 30772244
Perceptions of safety monitoring in CF clinical studies and potential impact on future study participation.
Kern-Goldberger AS, Hill-Ricciuti AC, Zhou JJ, Savant AP, Rugg L, Dozor AJ, Welter J, Saiman L, Quittell LM. Kern-Goldberger AS, et al. J Cyst Fibros. 2019 Jul;18(4):530-535. doi: 10.1016/j.jcf.2019.05.001. J Cyst Fibros. 2019. PMID: 31151855 Clinical Trial.